Metabolic Solutions raises $8.6M for diabetes drugs; WuXi to set up clinical trial group in China; Nabi earns $5M milestone;

Tools

@FierceBiotech: China: The next biotech superpower? Piece | Follow @FierceBiotech

@JohnCFierce: Shanghai Pharma looking for a mid-sized U.S. or European pharma buy. Reuters: News| Follow @JohnCFierce

@RyanMFierce: DREAM team finding best algorithms for inferring biological networks more complex than originally thought. Item | Follow @RyanMFierce

@MaureenFierce: 510(k) reform: IOM was right, NEJM says. Report | Follow @MaureenFierce

> Metabolic Solutions Development in Kalamazoo, MI says it has raised an additional $8.6 million to support its work on Type 2 diabetes drugs. Story

> WuXi PharmaTech has begun to set up a clinical trial services group in China. Report

> After being slammed by a recent failed late-stage study of NicVax, Nabi reports this morning that it earned a $5 million milestone. Nabi Release

> Titan Pharmaceuticals says it's gathered "additional positive results" from its Phase III confirmatory clinical study of the opioid dependence drug Probuphine. Release

Pharma News

@FiercePharma: Pfizer wins Viagra patent case against Teva. Story Court says drug protected from competition until 2019. | Follow @FiercePharma

> Pharma stages protest of South Korean price cuts. Report

> Shanghai looks to U.S., Europe for branded-drug buyout. News

> Icahn funds unload stakes in Biogen, Amgen. Article

Biotech Research News

> An optogenetic pacemaker would march to a fiber-optic beat. Details

> Genes reveal gender differences in alcoholism onset. Article

> Stanford researchers separate tumor-causing cells from therapeutic ones. News

> Researchers reach for broader firepower against viruses. More

> Jackson lab off the hook in Alzheimer's mice lawsuit. Report

> Heart regeneration, or finding our own inner zebrafish. Story

Manufacturing News

> Avastin fakes in China were not contaminated, investigation continues. More

> Harbin faces Chinese regulators for environmental violations. Article

> State incentives help hook Watson, Osmotica. News

> Generics deal sounds alarm for foreign API makers. Story

> 'Expendable' mid-managers are last defense for quality. Details

> Gilead clears GMP violations amid HIV drug approval. Report

And Finally... Looking to motivate more people, a new study says that just 15 minutes of moderate exercise a day will extend the average life span by three years. Story